Neoadjuvant Immune-checkpoint Blockade in Resectable Colon Cancer
Overview
Molecular Biology
Authors
Affiliations
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Pennel K, Hatthakarnkul P, Wood C, Lian G, Al-Badran S, Quinn J J Exp Clin Cancer Res. 2024; 43(1):64.
PMID: 38424636 PMC: 10905886. DOI: 10.1186/s13046-024-02958-4.
Chen J, Zhou Y, Han T, Wei J, Qiu M Front Immunol. 2023; 14:1269341.
PMID: 38022667 PMC: 10679411. DOI: 10.3389/fimmu.2023.1269341.
The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer.
Yu I, Wu R, Tokumaru Y, Terracina K, Takabe K Cancers (Basel). 2022; 14(22).
PMID: 36428777 PMC: 9688177. DOI: 10.3390/cancers14225685.
Hao Z, Parasramka S, Chen Q, Jacob A, Huang B, Mullett T Oncologist. 2022; 28(1):48-58.
PMID: 36200844 PMC: 9847538. DOI: 10.1093/oncolo/oyac209.
Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells.
Liao F, Zhang J, Hu Y, Najafabadi A, Moon J, Wicha M Cancer Immunol Immunother. 2022; 71(8):1959-1973.
PMID: 35098344 PMC: 10992978. DOI: 10.1007/s00262-021-03129-6.